Authors Kushner & colleagues shook the landscape of pharmacological weight loss with their findingsover one third of the 1,961 participants lost more than 20% of their body weight after 68 weeks
Clinical Trials Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weekly IcoSema, a fixed-ratio combination treatment consisting of basal insulin icodec and semaglutide
Loading and maintenance phases Some peptides benefit from loading phases with higher initial doses, followed by reduced maintenance dosing
Keeping Track of Your Tests Keep a record of your lab results
In this population, 53% of individuals had commercial health insurance, 18% had Medicare, 11% had Medicaid, 1% had Dual (Medicare/Medicaid) coverage, and 17% had other coverage (e.g., Tricare, Veterans Affairs, or other State or local programs)
4 Discussion In this multicenter, randomized, double-blind clinical trial, we assessed the efficacy and bioavailability of an innovative oral Sucrosomial B12 supplement, administered as a single daily dose of 1,000 g over a 7-day period